Navigation Links
Commonly used drug can limit radiation damage to lungs and heart for cancer patients
Date:4/21/2013

art soon after irradiation. So these new findings show that ACE inhibition decreases RILT by reducing direct acute heart damage."

Irradiating the heart leads to the development of fibrosis, which stiffens it, and this in turn leads to problems in the relaxation of the left ventricle. Due to this, blood flow from the lungs into the heart is hindered, and this can cause pulmonary damage. However, after treatment with captopril, the researchers observed an improvement in ventricular relaxation in the irradiated hearts.

Dr Van der Veen and her colleagues are now collaborating with a research group from the Mayo Clinic, Rochester, Minnesota (USA), in order to design a randomised clinical trial where patients who are treated with radiation to the thoracic area including the heart will be treated with either an ACE inhibitor or a placebo after irradiation.

Much progress has been made in radiation treatment over recent years, but in breast cancer, for example, most women still receive high doses to the heart, and this is known to increase the risk of heart disease. A recent study [3] has shown that for each Gray (Gy) [4] of radiation, there is a 7.4% increase in the occurrence of a subsequent major coronary event.

"Given that most women will receive a dose of between 1 and 5 Gray, and that the dangers are even greater for women with existing cardiac risk factors or coronary disease, this is still a big problem," said Dr Van der Veen.

Rats were chosen for the study because, unlike mice, they are big enough for researchers to be able to irradiate different part of the lungs and heart. The researchers believe that the way in which ACE inhibition works in both animals and humans is similar.

"We are confident that our clinical trial will see the same protective effect in humans as that which we have seen in rats," said Dr Van der Veen. "We will also now begin to study the late effects of ACE inhibition on RILT to see whe
'/>"/>

Contact: Mary Rice
mary.rice@riceconseil.eu
European Society for Radiotherapy and Oncology (ESTRO)
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Commonly used cholesterol calculation underestimates heart disease danger for many
2. UV Flash Infection Control Unit Steps onto the Healthcare Market, with a Quick and Effective Way to Disinfect Virtually any Item Commonly Found in Medical Facilities
3. New UAlberta research shows commonly prescribed medications could have adverse effects
4. Condition Commonly Seen in Aging May Alter Brain Function
5. Commonly used painkillers may protect against skin cancer
6. Memory, the adolescent brain and lying: The limits of neuroscientific evidence in the law
7. Career Confidential Announces Their Cover Letter Podcast Viewing Complimentary for a Limited Time
8. Asia-Pacific Seasonal Influenza Vaccine Market to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity : MarketResearchReports.biz
9. Ability to think about thinking not limited to humans
10. iPad Ultra Thin Aluminum Bluetooth Keyboard Case Released by iGearUnlimited
11. Kwiksure Discovers Uses and Limitations of Vehicle GPS in Hong Kong
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... Gummy smile surgeon, Dr. Alex Farnoosh, ... surgery, as well as the patented gum depigmentation treatmet. Dr. Farnoosh is a renowned ... many patients from around the world. , “Like treatment of any other disease or ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... State-designated entity on behalf of the New Jersey Department of Health, has received ... Information Technology, an agency of the U.S. Department of Health and Human Services ...
(Date:7/30/2015)... ... 2015 , ... New research finds some distinct differences in the way mesothelioma ... the Surviving Mesothelioma website. , Researchers with the National Institutes of Health, the ... of mesothelioma occurring between 1990 and 2010. Two percent of these cases (207) occurred ...
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... Bird ... offers a new bird hazing system to repel pest birds from the ... 60 diseases—including histoplasmosis, encephalitis, salmonella, meningitis, and toxoplasmosis, even the West Nile virus. When ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Author Dr. ... charge of their health in his new self-help book, “ Consciously Healing our Webs ... book promotes a simple message: “If we take responsibility for ourselves, we can create ...
Breaking Medicine News(10 mins):Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2Health News:Bird B Gone’s New Bird Hazing System Keeps Disease-Carrying Bird Droppings Out of Hospitals 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3
... to Fund Medical Assistance /MinnesotaCare Outreach and Enrollment Effort ... 13 Portico Healthnet, a non-profit agency working to ... care services, has been awarded more than $988,000 by ... to launch the Minnesota Coalition for Kids Health Coverage, ...
... WALTHAM, Mass., Oct. 13 Interleukin Genetics, Inc. (NYSE Amex: ... the fields of obesity and osteoporosis at medical meetings later this ... (ADA) Food and Nutrition Conference & Expo in Denver, Colo. ... IDF 20th World Diabetes Congress - Montreal, Canada . , ...
... Revenues for the US and European medical technology industry ... growth flattened out in the first half of 2009 ... seeks to maintain long-term momentum, including a stubborn funding ... and reimbursement environment. These and other findings are highlighted ...
... policies recommending that non-invasive ventilation be avoided during an ... link only http://www.cmaj.ca/embargo/cmaj081987.pdf ) in CMAJ ... argues that it should be used expeditiously in this ... to ventilate the lungs of patients in respiratory failure, ...
... ... medication information and rebate coupons through its physician network. Vivacare has recently enhanced the ... ... 13, 2009 -- Vivacare has made it easier for doctors to ...
... ... chairs into ergonomic computer workstations , ... Salisbury, NC (PRWEB) October 13, 2009 -- ErgoBiz, LLC, a manufacturer ... a revolutionary computer accessory that quickly converts most standard office chairs into an ergonomic ...
Cached Medicine News:Health News:Portico Healthnet Awarded $988K to Launch MN Coalition for Kids Health Coverage 2Health News:Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings 2Health News:Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings 3Health News:Global Medtech Industry Holds Steady Amidst Recession 2Health News:Global Medtech Industry Holds Steady Amidst Recession 3Health News:Global Medtech Industry Holds Steady Amidst Recession 4Health News:Should noninvasive ventilation be considered a high-risk procedure during an epidemic? 2Health News:Vivacare Delivers Medication Information to Patients through Doctor Websites 2Health News:Vivacare Delivers Medication Information to Patients through Doctor Websites 3Health News:Ergobiz Announces The Mobo Ergonomic Computer Station 2Health News:Ergobiz Announces The Mobo Ergonomic Computer Station 3
(Date:7/30/2015)... Net Sales of $1.17 billion represent a decrease of 1.3% ... 5.7% constant currency , Reported net loss per share ... share were $1.59, an increase of 0.6% over the prior ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported ... Company reported second quarter net sales of $1.17 billion, a ...
(Date:7/29/2015)... , July 30, 2015 Roche (SIX: RO, ... the cobas® EGFR Mutation Test v2 for Premarket ... Administration (FDA), as a companion diagnostic test for ... lung cancer patients with an acquired resistant mutation.  ... cancer who have adenocarcinoma with tumor containing an ...
(Date:7/29/2015)...  Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... supplier of injectable drug delivery systems, today announced the ... Company with flexibility and control to support its continued ... equity purchase agreement for up to $45 million with ... Chicago -based institutional investor, which provides the Company ...
Breaking Medicine Technology:Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 2Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 3Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 4Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 5Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 6Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 7Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 8Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 9Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 10Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 11Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 12Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 13Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 14Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 15Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 16Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 17Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 18Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 19Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 20Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 21Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 22Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 23Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 24Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 25Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 26Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 27Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 28Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 29Roche submits filing to FDA for companion diagnostic for non-small cell lung cancer drug therapy 2Roche submits filing to FDA for companion diagnostic for non-small cell lung cancer drug therapy 3Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4Unilife Announces Multifaceted Financing Strategy 5
... from a Children's Oncology Group (COG) Study ... Meeting -, CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ ... on developing monoclonal,antibodies to treat cancer and ... epratuzumab plus standard,chemotherapy is feasible and well ...
... Plenary Session Reports EORTC 40983 (EPOC),Intergroup Study ... Results of the,randomized phase III EORTC 40983 ... first time that peri-operative (pre and post,surgery) ... standard chemotherapy regimen for colon cancer,5-fluorouracil/leucovorin (5-FU/LV)) ...
Cached Medicine Technology:Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 2Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 3Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 4Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 5The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 2The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 3The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 4The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 5The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 6The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 7The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 8The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 9
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: